EquityGlobal - OtherVery High Risk
Direct
NAV (17-Apr-25)
Returns (Since Inception)
Fund Size
₹3,019 Cr
Expense Ratio
1.25%
ISIN
INF109K01Z71
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
02 Jan 2013
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-2.02%
— (Cat Avg.)
3 Years
+7.64%
— (Cat Avg.)
5 Years
+12.71%
— (Cat Avg.)
10 Years
+12.87%
— (Cat Avg.)
Since Inception
+14.98%
— (Cat Avg.)
Equity | ₹2,971.18 Cr | 98.41% |
Others | ₹47.95 Cr | 1.59% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Huntington Ingalls Industries Inc | Equity | ₹94.63 Cr | 3.13% |
West Pharmaceutical Services Inc | Equity | ₹90.05 Cr | 2.98% |
Corteva Inc | Equity | ₹88.78 Cr | 2.94% |
Zimmer Biomet Holdings Inc | Equity | ₹82.33 Cr | 2.73% |
Brown-Forman Corp Registered Shs -B- Non Vtg | Equity | ₹81.79 Cr | 2.71% |
Veeva Systems Inc Class A | Equity | ₹81.24 Cr | 2.69% |
The Campbell's Co | Equity | ₹78.59 Cr | 2.60% |
The Walt Disney Co | Equity | ₹78.5 Cr | 2.60% |
Boeing Co | Equity | ₹78.21 Cr | 2.59% |
Monolithic Power Systems Inc | Equity | ₹73.84 Cr | 2.45% |
Pfizer Inc | Equity | ₹73.29 Cr | 2.43% |
Danaher Corp | Equity | ₹70.18 Cr | 2.32% |
MarketAxess Holdings Inc | Equity | ₹70.15 Cr | 2.32% |
U.S. Bancorp | Equity | ₹70.11 Cr | 2.32% |
Constellation Brands Inc Class A | Equity | ₹69.11 Cr | 2.29% |
Allegion PLC | Equity | ₹68.09 Cr | 2.26% |
The Estee Lauder Companies Inc Class A | Equity | ₹65.16 Cr | 2.16% |
International Flavors & Fragrances Inc | Equity | ₹64.09 Cr | 2.12% |
NXP Semiconductors NV | Equity | ₹63.11 Cr | 2.09% |
Medtronic PLC | Equity | ₹62.71 Cr | 2.08% |
Agilent Technologies Inc | Equity | ₹62.6 Cr | 2.07% |
Microchip Technology Inc | Equity | ₹62.57 Cr | 2.07% |
Adobe Inc | Equity | ₹61.54 Cr | 2.04% |
Comcast Corp Class A | Equity | ₹60.89 Cr | 2.02% |
United Parcel Service Inc Class B | Equity | ₹60.81 Cr | 2.01% |
Nike Inc Class B | Equity | ₹60.62 Cr | 2.01% |
TransUnion | Equity | ₹59.51 Cr | 1.97% |
Bio-Rad Laboratories Inc Class A | Equity | ₹59.02 Cr | 1.95% |
Charles Schwab Corp | Equity | ₹54.32 Cr | 1.80% |
Alphabet Inc Class C | Equity | ₹53.05 Cr | 1.76% |
Net Current Assets | Cash | ₹45.38 Cr | 1.50% |
Mondelez International Inc Class A | Equity | ₹43.55 Cr | 1.44% |
Amazon.com Inc | Equity | ₹43.23 Cr | 1.43% |
Equifax Inc | Equity | ₹41.25 Cr | 1.37% |
Northrop Grumman Corp | Equity | ₹40.58 Cr | 1.34% |
Synopsys Inc | Equity | ₹38.17 Cr | 1.26% |
Cadence Design Systems Inc | Equity | ₹37.64 Cr | 1.25% |
Manhattan Associates Inc | Equity | ₹35.88 Cr | 1.19% |
Microsoft Corp | Equity | ₹35.65 Cr | 1.18% |
Gilead Sciences Inc | Equity | ₹34.93 Cr | 1.16% |
Oracle Corp | Equity | ₹34.26 Cr | 1.13% |
Thermo Fisher Scientific Inc | Equity | ₹33.73 Cr | 1.12% |
Lam Research Corp | Equity | ₹33.42 Cr | 1.11% |
Merck & Co Inc | Equity | ₹33.03 Cr | 1.09% |
Biogen Inc | Equity | ₹30.86 Cr | 1.02% |
Applied Materials Inc | Equity | ₹29.81 Cr | 0.99% |
Amgen Inc | Equity | ₹29.33 Cr | 0.97% |
Bristol-Myers Squibb Co | Equity | ₹28.42 Cr | 0.94% |
Autodesk Inc | Equity | ₹28.17 Cr | 0.93% |
Masco Corp | Equity | ₹27.06 Cr | 0.90% |
Kenvue Inc | Equity | ₹26.69 Cr | 0.88% |
Altria Group Inc | Equity | ₹25.88 Cr | 0.86% |
Teradyne Inc | Equity | ₹22.42 Cr | 0.74% |
Occidental Petroleum Corp | Equity | ₹20.19 Cr | 0.67% |
Qualcomm Inc | Equity | ₹17.57 Cr | 0.58% |
EPAM Systems Inc | Equity | ₹16.14 Cr | 0.53% |
IDEX Corp | Equity | ₹16.02 Cr | 0.53% |
Freeport-McMoRan Inc | Equity | ₹15.98 Cr | 0.53% |
Salesforce Inc | Equity | ₹14.11 Cr | 0.47% |
Yum China Holdings Inc | Equity | ₹11.08 Cr | 0.37% |
Globant SA | Equity | ₹10.55 Cr | 0.35% |
ASML Holding NV ADR | Equity | ₹9.07 Cr | 0.30% |
Clorox Co | Equity | ₹7.62 Cr | 0.25% |
Treps | Cash - Repurchase Agreement | ₹2.57 Cr | 0.09% |
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹771.72 Cr | 25.56% |
Technology | ₹623.92 Cr | 20.67% |
Industrials | ₹426.64 Cr | 14.13% |
Consumer Defensive | ₹398.39 Cr | 13.20% |
Financial Services | ₹254.09 Cr | 8.42% |
Communication Services | ₹192.45 Cr | 6.37% |
Basic Materials | ₹168.85 Cr | 5.59% |
Consumer Cyclical | ₹114.93 Cr | 3.81% |
Energy | ₹20.19 Cr | 0.67% |
Standard Deviation
This fund
18.84%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.25
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since September 2024
Since July 2022
Since November 2024
ISIN INF109K01Z71 | Expense Ratio 1.25% | Exit Load 1.00% | Fund Size ₹3,019 Cr | Age 12 years 3 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark S&P 500 TR USD |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹8,67,406 Cr
Address
3rd Floor, Hallmark Business Plaza, Mumbai, 400 051
Your principal amount will be at Very High Risk
EquityGlobal - OtherVery High Risk
Direct
NAV (17-Apr-25)
Returns (Since Inception)
Fund Size
₹3,019 Cr
Expense Ratio
1.25%
ISIN
INF109K01Z71
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
02 Jan 2013
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-2.02%
— (Cat Avg.)
3 Years
+7.64%
— (Cat Avg.)
5 Years
+12.71%
— (Cat Avg.)
10 Years
+12.87%
— (Cat Avg.)
Since Inception
+14.98%
— (Cat Avg.)
Equity | ₹2,971.18 Cr | 98.41% |
Others | ₹47.95 Cr | 1.59% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Huntington Ingalls Industries Inc | Equity | ₹94.63 Cr | 3.13% |
West Pharmaceutical Services Inc | Equity | ₹90.05 Cr | 2.98% |
Corteva Inc | Equity | ₹88.78 Cr | 2.94% |
Zimmer Biomet Holdings Inc | Equity | ₹82.33 Cr | 2.73% |
Brown-Forman Corp Registered Shs -B- Non Vtg | Equity | ₹81.79 Cr | 2.71% |
Veeva Systems Inc Class A | Equity | ₹81.24 Cr | 2.69% |
The Campbell's Co | Equity | ₹78.59 Cr | 2.60% |
The Walt Disney Co | Equity | ₹78.5 Cr | 2.60% |
Boeing Co | Equity | ₹78.21 Cr | 2.59% |
Monolithic Power Systems Inc | Equity | ₹73.84 Cr | 2.45% |
Pfizer Inc | Equity | ₹73.29 Cr | 2.43% |
Danaher Corp | Equity | ₹70.18 Cr | 2.32% |
MarketAxess Holdings Inc | Equity | ₹70.15 Cr | 2.32% |
U.S. Bancorp | Equity | ₹70.11 Cr | 2.32% |
Constellation Brands Inc Class A | Equity | ₹69.11 Cr | 2.29% |
Allegion PLC | Equity | ₹68.09 Cr | 2.26% |
The Estee Lauder Companies Inc Class A | Equity | ₹65.16 Cr | 2.16% |
International Flavors & Fragrances Inc | Equity | ₹64.09 Cr | 2.12% |
NXP Semiconductors NV | Equity | ₹63.11 Cr | 2.09% |
Medtronic PLC | Equity | ₹62.71 Cr | 2.08% |
Agilent Technologies Inc | Equity | ₹62.6 Cr | 2.07% |
Microchip Technology Inc | Equity | ₹62.57 Cr | 2.07% |
Adobe Inc | Equity | ₹61.54 Cr | 2.04% |
Comcast Corp Class A | Equity | ₹60.89 Cr | 2.02% |
United Parcel Service Inc Class B | Equity | ₹60.81 Cr | 2.01% |
Nike Inc Class B | Equity | ₹60.62 Cr | 2.01% |
TransUnion | Equity | ₹59.51 Cr | 1.97% |
Bio-Rad Laboratories Inc Class A | Equity | ₹59.02 Cr | 1.95% |
Charles Schwab Corp | Equity | ₹54.32 Cr | 1.80% |
Alphabet Inc Class C | Equity | ₹53.05 Cr | 1.76% |
Net Current Assets | Cash | ₹45.38 Cr | 1.50% |
Mondelez International Inc Class A | Equity | ₹43.55 Cr | 1.44% |
Amazon.com Inc | Equity | ₹43.23 Cr | 1.43% |
Equifax Inc | Equity | ₹41.25 Cr | 1.37% |
Northrop Grumman Corp | Equity | ₹40.58 Cr | 1.34% |
Synopsys Inc | Equity | ₹38.17 Cr | 1.26% |
Cadence Design Systems Inc | Equity | ₹37.64 Cr | 1.25% |
Manhattan Associates Inc | Equity | ₹35.88 Cr | 1.19% |
Microsoft Corp | Equity | ₹35.65 Cr | 1.18% |
Gilead Sciences Inc | Equity | ₹34.93 Cr | 1.16% |
Oracle Corp | Equity | ₹34.26 Cr | 1.13% |
Thermo Fisher Scientific Inc | Equity | ₹33.73 Cr | 1.12% |
Lam Research Corp | Equity | ₹33.42 Cr | 1.11% |
Merck & Co Inc | Equity | ₹33.03 Cr | 1.09% |
Biogen Inc | Equity | ₹30.86 Cr | 1.02% |
Applied Materials Inc | Equity | ₹29.81 Cr | 0.99% |
Amgen Inc | Equity | ₹29.33 Cr | 0.97% |
Bristol-Myers Squibb Co | Equity | ₹28.42 Cr | 0.94% |
Autodesk Inc | Equity | ₹28.17 Cr | 0.93% |
Masco Corp | Equity | ₹27.06 Cr | 0.90% |
Kenvue Inc | Equity | ₹26.69 Cr | 0.88% |
Altria Group Inc | Equity | ₹25.88 Cr | 0.86% |
Teradyne Inc | Equity | ₹22.42 Cr | 0.74% |
Occidental Petroleum Corp | Equity | ₹20.19 Cr | 0.67% |
Qualcomm Inc | Equity | ₹17.57 Cr | 0.58% |
EPAM Systems Inc | Equity | ₹16.14 Cr | 0.53% |
IDEX Corp | Equity | ₹16.02 Cr | 0.53% |
Freeport-McMoRan Inc | Equity | ₹15.98 Cr | 0.53% |
Salesforce Inc | Equity | ₹14.11 Cr | 0.47% |
Yum China Holdings Inc | Equity | ₹11.08 Cr | 0.37% |
Globant SA | Equity | ₹10.55 Cr | 0.35% |
ASML Holding NV ADR | Equity | ₹9.07 Cr | 0.30% |
Clorox Co | Equity | ₹7.62 Cr | 0.25% |
Treps | Cash - Repurchase Agreement | ₹2.57 Cr | 0.09% |
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹771.72 Cr | 25.56% |
Technology | ₹623.92 Cr | 20.67% |
Industrials | ₹426.64 Cr | 14.13% |
Consumer Defensive | ₹398.39 Cr | 13.20% |
Financial Services | ₹254.09 Cr | 8.42% |
Communication Services | ₹192.45 Cr | 6.37% |
Basic Materials | ₹168.85 Cr | 5.59% |
Consumer Cyclical | ₹114.93 Cr | 3.81% |
Energy | ₹20.19 Cr | 0.67% |
Standard Deviation
This fund
18.84%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.25
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since September 2024
Since July 2022
Since November 2024
ISIN INF109K01Z71 | Expense Ratio 1.25% | Exit Load 1.00% | Fund Size ₹3,019 Cr | Age 12 years 3 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark S&P 500 TR USD |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹8,67,406 Cr
Address
3rd Floor, Hallmark Business Plaza, Mumbai, 400 051
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments